Core Laboratories Inc. (NYSE:CLB – Get Free Report) rose 5.9% during trading on Wednesday . The company traded as high as $12.20 and last traded at $12.0870. Approximately 264,549 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 573,573 shares. The stock had previously closed at $11.41.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on CLB shares. Wall Street Zen lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings cut shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce”.
Read Our Latest Analysis on Core Laboratories
Core Laboratories Price Performance
Core Laboratories (NYSE:CLB – Get Free Report) last announced its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, meeting analysts’ consensus estimates of $0.06. The business had revenue of $121.80 million during the quarter, compared to analysts’ expectations of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.14 earnings per share. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Analysts predict that Core Laboratories Inc. will post 0.53 EPS for the current fiscal year.
Core Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Monday, May 11th. Core Laboratories’s dividend payout ratio (DPR) is currently 6.15%.
Institutional Trading of Core Laboratories
Several hedge funds have recently bought and sold shares of CLB. Goldman Sachs Group Inc. increased its position in Core Laboratories by 185.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock worth $13,549,000 after buying an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN lifted its position in shares of Core Laboratories by 9.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after buying an additional 528,976 shares in the last quarter. MAC Alpha Capital Management LP purchased a new position in shares of Core Laboratories during the 4th quarter valued at about $5,016,000. Heartland Advisors Inc. bought a new position in shares of Core Laboratories during the 1st quarter valued at approximately $2,518,000. Finally, Renaissance Technologies LLC grew its stake in shares of Core Laboratories by 436.6% during the 4th quarter. Renaissance Technologies LLC now owns 183,400 shares of the oil and gas company’s stock valued at $2,940,000 after acquiring an additional 149,219 shares during the period. Institutional investors own 97.81% of the company’s stock.
About Core Laboratories
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Stories
- Five stocks we like better than Core Laboratories
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
- Boxabl Disrupts Housing With A Tiny Float IPO
- Robotaxi Mode Engaged: Tesla Starts Monetizing Its Florida Fleet
- Velo3D Forges a New Reality After Its Sharp Stock Sell-Off
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}